Systemic comorbidities in patients with adenomyosis
Reproductive BioMedicine Online · 2025
DOI: 10.1016/j.rbmo.2025.105102 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Reproductive BioMedicine Online, 2025. Verfasst von Angela Gallone und 8 weiteren Autor:innen. Beteiligte Einrichtung: Obstetrics and Gynaecology, Department of Experimental Clinical Biomedical Sciences, University of Florence, Careggi University Hospital, Florence, I…. Hauptthemen laut MEDLINE: Adenomyosis, Endometriosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
RESEARCH QUESTION: How do comorbidities and their prevalence differ between patients with adenomyosis alone and patients with both adenomyosis and endometriosis? DESIGN: A prospective observational study compared the presence of comorbidities between patients with adenomyosis alone (n = 342) and patients with both adenomyosis and endometriosis (n = 347). Premenopausal patients aged 20-50 years, excluding those with malignant diseases, were studied. The diagnosis of endometriosis or adenomyosis was made by transvaginal ultrasound, magnetic resonance imaging or surgery. Comorbidities were classified as either (i) autoimmune or (ii) stress- and pain-related. RESULTS: Patients with adenomyosis alone had a significantly lower prevalence of comorbidities compared with patients with both adenomyosis and endometriosis [44.7% (152/342) versus 55.0% (191/34); P = 0.007]. Autoimmune diseases [14% (48/342) versus 23.9% (83/247); P = 0.001] and stress- and pain-related disorders [30.4% (104/342) versus 46.4% (161/347); P 35 years with adenomyosis alone were less likely to have autoimmune comorbidities compared with patients with both adenomyosis and endometriosis [5.8% (20/48) versus 12.6% (44/347); P = 0.002]. Co-existence of endometriosis was independently associated with the presence of comorbidities among patients with adenomyosis (OR = 1.65, 95% CI 1.12-2.42; P = 0.01). CONCLUSIONS: Patients with adenomyosis alone had a lower prevalence of comorbidities compared with patients with both adenomyosis and endometriosis, suggesting a different clinical profile. More epidemiological data will be useful to explain the low prevalence of some systemic comorbidities in patients with adenomyosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Obstetrics and Gynaecology, Department of Experimental Clinical Biomedical Sciences, University of Florence, Careggi University Hospital, Florence, Italy.
- Escuela de Postgrado en Salud, Universidad Espiritu Santo, Samborondon, Ecuador
- Obstetrics and Gynaecology, Department of Experimental Clinical Biomedical Sciences, University of Florence, Careggi University Hospital, Florence, Italy. Electronic address: felice.petraglia@unifi.it.
Zitieren
APA
Gallone, A., Vannuccini, S., Manzi, V., La Torre, F., Toscano, F., Giani, M., Fambrini, M., Chedraui, P., & Petraglia, F. (2025). Systemic comorbidities in patients with adenomyosis. Reproductive BioMedicine Online. https://doi.org/10.1016/j.rbmo.2025.105102
Vancouver
Gallone A, Vannuccini S, Manzi V, La Torre F, Toscano F, Giani M, et al. Systemic comorbidities in patients with adenomyosis. Reproductive BioMedicine Online. 2025. doi:10.1016/j.rbmo.2025.105102
BibTeX
@article{Gallone2025,
author = {Gallone, Angela and Vannuccini, Silvia and Manzi, Virginia and La Torre, Francesco and Toscano, Federico and Giani, Milo and Fambrini, Massimiliano and Chedraui, Peter and Petraglia, Felice},
title = {Systemic comorbidities in patients with adenomyosis},
journal = {Reproductive BioMedicine Online},
year = {2025},
doi = {10.1016/j.rbmo.2025.105102}
}
EUVIMED